Robert Maynard

1.7k total citations
25 papers, 1.3k citations indexed

About

Robert Maynard is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Robert Maynard has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Rheumatology. Recurrent topics in Robert Maynard's work include Osteoarthritis Treatment and Mechanisms (8 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related Molecular Pathways (4 papers). Robert Maynard is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related Molecular Pathways (4 papers). Robert Maynard collaborates with scholars based in United States, United Kingdom and Netherlands. Robert Maynard's co-authors include Joseph Geradts, Ralph H. Hruban, Mieke Schutte, Steven E. Kern, Stephan A. Hahn, Wolff Schmiegel, Stephen B. Baylin, Sridhar K. Rabindran, Christopher A. Moskaluk and Irmgard Schwarte‐Waldhoff and has published in prestigious journals such as PLoS ONE, American Journal Of Pathology and Infection and Immunity.

In The Last Decade

Robert Maynard

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Maynard United States 14 812 569 381 266 156 25 1.3k
Stavros Vassiliou Greece 23 485 0.6× 470 0.8× 496 1.3× 155 0.6× 84 0.5× 66 1.3k
Christopher Tay Australia 17 781 1.0× 488 0.9× 138 0.4× 154 0.6× 229 1.5× 18 2.5k
Y. Ogata Japan 11 427 0.5× 285 0.5× 610 1.6× 132 0.5× 117 0.8× 34 1.1k
Nathalie Cloutier Canada 17 270 0.3× 929 1.6× 332 0.9× 102 0.4× 143 0.9× 26 1.6k
Maria Cristina Curia Italy 22 793 1.0× 691 1.2× 224 0.6× 183 0.7× 50 0.3× 61 1.7k
Paul Drillenburg Netherlands 20 442 0.5× 374 0.7× 196 0.5× 388 1.5× 38 0.2× 37 1.4k
Nobuaki Fujise Japan 13 1.3k 1.6× 1.7k 3.0× 338 0.9× 227 0.9× 262 1.7× 23 2.2k
Toshifumi Fujiwara Japan 19 293 0.4× 522 0.9× 239 0.6× 139 0.5× 116 0.7× 74 1.2k
K Kinoshita Japan 16 298 0.4× 425 0.7× 192 0.5× 308 1.2× 72 0.5× 65 1.2k
Isabel Ruiz‐Ávila Spain 27 608 0.7× 477 0.8× 203 0.5× 419 1.6× 49 0.3× 63 2.0k

Countries citing papers authored by Robert Maynard

Since Specialization
Citations

This map shows the geographic impact of Robert Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Maynard more than expected).

Fields of papers citing papers by Robert Maynard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Maynard. The network helps show where Robert Maynard may publish in the future.

Co-authorship network of co-authors of Robert Maynard

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Maynard. A scholar is included among the top collaborators of Robert Maynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Maynard. Robert Maynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maynard, Robert, et al.. (2023). Analytical Performance Evaluation of Three Point-of-Care CBC Analyzers for Management of Clozapine Therapy in Ambulatory Psychiatry Clinics. The Journal of Applied Laboratory Medicine. 8(6). 1028–1041.
2.
Maynard, Robert, et al.. (2023). Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient. Practical Laboratory Medicine. 36. e00322–e00322. 4 indexed citations
3.
4.
Maynard, Robert, Nichole Korpi‐Steiner, & Steven W. Cotten. (2022). Concordance of Chronic Kidney Disease Stage and Metformin Management Using CKD-EPI 2021 Race-Free Equation vs CKD-EPI 2009 Equation to Estimate Glomerular Filtration Rate. Clinical Chemistry. 69(2). 202–204. 2 indexed citations
5.
Bell, Richard D., Marian James, Robert Maynard, et al.. (2021). IKKβ–NF-κB signaling in adult chondrocytes promotes the onset of age-related osteoarthritis in mice. Science Signaling. 14(701). eabf3535–eabf3535. 32 indexed citations
6.
Doolittle, Madison L., Gina M. Calabrese, Larry D. Mesner, et al.. (2020). Genetic analysis of osteoblast activity identifies Zbtb40 as a regulator of osteoblast activity and bone mass. PLoS Genetics. 16(6). e1008805–e1008805. 14 indexed citations
7.
Maynard, Robert, et al.. (2020). Surgical Induction of Posttraumatic Osteoarthritis in the Mouse. Methods in molecular biology. 91–103. 3 indexed citations
8.
Maynard, Robert & Cheryl L. Ackert‐Bicknell. (2019). Mouse Models and Online Resources for Functional Analysis of Osteoporosis Genome-Wide Association Studies. Frontiers in Endocrinology. 10. 277–277. 12 indexed citations
9.
10.
Schott, Eric M., Robert Maynard, Zhaoyang Liu, et al.. (2017). Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis. PLoS ONE. 12(4). e0174705–e0174705. 43 indexed citations
11.
Maynard, Robert, Eric M. Schott, Robert A. Mooney, et al.. (2016). Oral hydrolyzed type 1 collagen induces chondroregeneration and inhibits synovial inflammation in murine posttraumatic osteoarthritis. Osteoarthritis and Cartilage. 24. S532–S533. 3 indexed citations
12.
Hamada, Daisuke, Robert Maynard, Stephen L. Kates, et al.. (2014). Insulin selectively suppresses TNFα/IL-1β-induced catabolic enzymes in Ostezoarthritic fibroblast-like synovziocytes. Osteoarthritis and Cartilage. 22. S451–S452. 1 indexed citations
13.
Hamada, Daisuke, Erik R. Sampson, Robert Maynard, & Michael J. Zuscik. (2014). Surgical Induction of Posttraumatic Osteoarthritis in the Mouse. Methods in molecular biology. 1130. 61–72. 15 indexed citations
14.
Sampson, Erik R., Robert Maynard, Regis J. O’Keefe, et al.. (2012). Ski inhibits TGF‐β/phospho‐Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes. Journal of Cellular Biochemistry. 113(6). 2156–2166. 34 indexed citations
15.
Diaz, MO, Robert Maynard, & N. Brum‐Zorrilla. (2010). Diffuse Centromere and Chromosome Polymorphism in Haplogyne Spiders of the Families Dysderidae and Segestriidae. Cytogenetic and Genome Research. 128(1-3). 131–138. 7 indexed citations
16.
Geradts, Joseph, Ralph H. Hruban, Mieke Schutte, Scott E. Kern, & Robert Maynard. (2000). Immunohistochemical p16INK4a Analysis of Archival Tumors with Deletion, Hypermethylation, or Mutation of the CDKN2/MTS1 Gene. Applied immunohistochemistry & molecular morphology. 8(1). 71–79. 50 indexed citations
17.
Geradts, Joseph, Ralph H. Hruban, Mieke Schutte, Scott E. Kern, & Robert Maynard. (2000). . Applied Immunohistochemistry. 8(1). 71–79. 13 indexed citations
18.
Geradts, Joseph, Kwun M. Fong, P. V. Zimmerman, Robert Maynard, & John D. Minna. (1999). Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.. PubMed. 5(4). 791–800. 93 indexed citations
19.
Geradts, Joseph, Robert Maynard, Michael J. Birrer, et al.. (1999). Frequent Loss of KAI1 Expression in Squamous and Lymphoid Neoplasms. American Journal Of Pathology. 154(6). 1665–1671. 37 indexed citations
20.
Wilentz, Robb E., Joseph Geradts, Robert Maynard, et al.. (1998). Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.. PubMed. 58(20). 4740–4. 261 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stavros Vassiliou Breakdown of academic impact, for papers by Christopher Tay Breakdown of academic impact, for papers by Y. Ogata Breakdown of academic impact, for papers by Nathalie Cloutier Breakdown of academic impact, for papers by Maria Cristina Curia Breakdown of academic impact, for papers by Paul Drillenburg Breakdown of academic impact, for papers by Nobuaki Fujise Breakdown of academic impact, for papers by Toshifumi Fujiwara Breakdown of academic impact, for papers by K Kinoshita Breakdown of academic impact, for papers by Isabel Ruiz‐Ávila
Rankless by CCL
2026